MP 116 (Sulindac 200 mg)
Pill imprint MP 116 has been identified as Sulindac 200 mg.
Sulindac is used in the treatment of ankylosing spondylitis; gout, acute; pain; familial adenomatous polyposis; osteoarthritis (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Risk cannot be ruled out during pregnancy. Sulindac 200 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 200 mg
- 10.00 mm
- Prescription only
|NDC Code||Manufacturer / Repackager|
|54569-4032||A-S Medication Solutions, LLC (repackager)|
|63874-0350||Altura Pharmaceuticals Inc (repackager)|
|66336-0686||Dispensing Solutions Inc. (repackager)|
|16590-0211||Stat RX USA LLC (repackager)|
|68387-0588||Keltman Pharmaceuticals Inc (repackager)|
|23490-6318||Palmetto State Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about sulindac
- Other brands: Clinoril
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.